These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3943033)

  • 1. Use of VP-16-213 in the treatment of familial erythrophagocytic lymphohistiocytosis.
    Alvarado CS; Buchanan GR; Kim TH; Zaatari G; Sartain P; Ragab AH
    Cancer; 1986 Mar; 57(6):1097-100. PubMed ID: 3943033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of four patients with erythrophagocytic lymphohistiocytosis by a combination of epipodophyllotoxin, steroids, intrathecal methotrexate, and cranial irradiation.
    Fischer A; Virelizier JL; Arenzana-Seisdedos F; Perez N; Nezelof C; Griscelli C
    Pediatrics; 1985 Aug; 76(2):263-8. PubMed ID: 3839578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful induction with chemotherapy including teniposide in familial erythrophagocytic lymphohistiocytosis.
    Henter JI; Elinder G; Finkel Y; Söder O
    Lancet; 1986 Dec; 2(8520):1402. PubMed ID: 2878264
    [No Abstract]   [Full Text] [Related]  

  • 4. [Deteriorating natural killer activity in familial erythrophagocytic lymphohistiocytosis].
    Caballero García M; Mar Molinero F; Melián Machín A; Sánchez Díaz JI; Mollejo Villanueva M; Sotelo MT; Nogales Espert A
    An Esp Pediatr; 1988 Aug; 29(2):139-42. PubMed ID: 3190019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment of lymphohistiocytic reticulosis with phagocytosis with epipodophyllotoxin VP 16-213.
    Ambruso DR; Hays T; Zwartjes WJ; Tubergen DG; Favara BE
    Cancer; 1980 May; 45(10):2516-20. PubMed ID: 7378987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Familial erythrophagocytic lymphohistiocytosis: treatment with vinblastine-loaded platelets.
    Woo SY; Klappenbach RS; McCullars GM; Kerwin DM; Rowden G; Sinks LF
    Cancer; 1980 Dec; 46(12):2566-70. PubMed ID: 7192595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant histiocytosis. Response to VP-16-213 and cytosine arabinoside.
    Vera R; Bertino JR; Cadman E; Waldron JA
    Cancer; 1984 Sep; 54(6):991-3. PubMed ID: 6467142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VP-16 in combinations for first-line treatment of malignant germ-cell tumors and gestational choriocarcinoma.
    Newlands ES
    Semin Oncol; 1985 Mar; 12(1 Suppl 2):37-41. PubMed ID: 2579442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Familial erythrocyto-phagocytic lymphohistiocytosis--successful treatment of 4 children].
    Elinder G; Finkel Y; Henter JI; Holmström S; Söder O; Karlén J; Sahlgren B
    Lakartidningen; 1987 Feb; 84(7):459-61. PubMed ID: 3561109
    [No Abstract]   [Full Text] [Related]  

  • 10. The treatment of familial erythrophagocytic lymphohistiocytosis.
    Lilleyman JS
    Cancer; 1980 Aug; 46(3):468-70. PubMed ID: 6893166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Etoposide (VP 16/NK 171) and cytosine arabinoside combination chemotherapy in refractory childhood leukemia].
    Esumi N; Todo S; Arakawa S; Imashuku S
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):951-8. PubMed ID: 3963859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VP 16-213 and cyclophosphamide in the treatment of refractory acute nonlymphocytic leukemia with monocytic features.
    Hurd DD; Peterson BA; McKenna RW; Bloomfield CD
    Med Pediatr Oncol; 1981; 9(3):251-5. PubMed ID: 7017368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of VP-16 and the combination of adriamycin and vincristine in advanced breast cancer.
    Eagan RT; Ahmann DL; Bisel HF
    Oncology; 1976; 33(3):146-8. PubMed ID: 1012648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial erythrophagocytic reticulosis. Complete response to combination chemotherapy.
    Delaney MM; Shafford EA; Al-Attar A; Pritchard J
    Arch Dis Child; 1984 Feb; 59(2):173-5. PubMed ID: 6546659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II trial of oral VP 16-213 (etoposide) in patients with advanced head and neck cancer.
    Crivellari D; Veronesi A; Magri MD; Tirelli U; Comoretto R; Barzan L; Caruso G; Carbone A; Grigoletto E
    Tumori; 1985 Oct; 71(5):499-500. PubMed ID: 4060251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial erythrophagocytic lymphohistiocytosis.
    van Acker KJ; Roodhooft AM
    Tijdschr Kindergeneeskd; 1984 Oct; 52(5):192-6. PubMed ID: 6515630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial erythrophagocytic lymphohistiocytosis: late relapse despite continuous high-dose VP-16 chemotherapy.
    Ware R; Friedman HS; Kinney TR; Kurtzberg J; Chaffee S; Falletta JM
    Med Pediatr Oncol; 1990; 18(1):27-9. PubMed ID: 2294389
    [No Abstract]   [Full Text] [Related]  

  • 18. Oral VP-16-213 in advanced bronchogenic carcinoma and toxic effects when combined with methotrexate.
    Anderson G; Bowyer F; Williams L
    Thorax; 1981 Jun; 36(6):462-4. PubMed ID: 7314017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial erythrophagocytic lymphohistiocytosis.
    Loy TS; Diaz-Arias AA; Perry MC
    Semin Oncol; 1991 Feb; 18(1):34-8. PubMed ID: 1992522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of VP-16-213 in malignant lymphoma and melanoma.
    Cecil JW; Quagliana JM; Coltman CA; Al-Sarraf M; Thigpen T; Groppe CW
    Cancer Treat Rep; 1978 May; 62(5):801-3. PubMed ID: 657164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.